Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
A Phase II of Entospletinib, a SYK Inhibitor, First line cGVHD patients
Clinical Trial Grant
Duke Scholars
Principal Investigator
Stefanie Sarantopoulos
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Gilead Sciences, Inc.
Start Date
May 31, 2016
End Date
March 22, 2019
Awarded By
Gilead Sciences, Inc.
Start Date
May 31, 2016
End Date
March 22, 2019
